Skip to main navigation
Skip to search
Skip to main content
Sort by
Immunology and Microbiology
Human Immunodeficiency Virus 1
100%
Human Immunodeficiency Virus
41%
Virus
36%
Viral Load
35%
Reverse Transcriptase
23%
Blood Plasma
20%
Omicron Coronavirus Variant
19%
CD4 Lymphocyte Count
18%
Breakthrough Infection
17%
Cross-Resistance
17%
Peripheral Blood Mononuclear Cell
15%
Structural Gene
14%
Neutralization
13%
Severe Acute Respiratory Syndrome Coronavirus 2
12%
Prevalence
12%
Drug Resistance
12%
Cladistics
11%
Virus Infectivity
11%
T-Helper Cell
10%
CD4
9%
CCR5
8%
Virus Type
8%
Neutralizing Antibody
8%
DNA Sequence
7%
Molecular Epidemiology
7%
Wild Type
7%
Spike
6%
Sequence Analysis
5%
Recombinant Virus
5%
Human Immunodeficiency Virus Type 1 Subtype C
5%
Virion
5%
T Cell Depletion
5%
Sample Size
5%
DNA Extraction
5%
Hepatitis C Virus
5%
Virus Neutralization
5%
HIV Type 1
5%
Caspase 1
5%
Codon
5%
Humanized Mouse
5%
T Cell
5%
Drug Therapy
5%
Population Dynamics
5%
Complement Activation
5%
Factor H
5%
Genetic Variability
5%
Keyphrases
HIV Protease Inhibitors
11%
Highly Active Antiretroviral Therapy (HAART)
11%
Resistance Test
7%
Genetic Resistance
6%
Virus Type
5%
Population Dynamics
5%
Social Accountability
5%
Omicron Infection
5%
Omicron Sub-lineages
5%
Health Facility Committees
5%
Secondary mutation
5%
HIV-associated
5%
Fusion Inhibitor
5%
HIV-1 Envelope
5%
Enfuvirtide
5%
Genetic Context
5%
Viral Infectivity
5%
Viral Assay
5%
SARS-CoV-2 Surrogate
5%
Surrogate Neutralization
5%
Surrogate Virus Neutralization Test (sVNT)
5%
Migration Rate
5%
HIV-1 non-B Subtypes
5%
Native Population
5%
Volumetric Flow
5%
Replication Capacity
5%
HIV-1 Subtype C
5%
Cell-to-cell Transmission
5%
Editing Software
5%
Simple DNA Extraction
5%
HIV Drug Resistance Testing
5%
Sequence Editing
5%
CD4+ T Cell Depletion
5%
VX-765
5%
Caspase-1 Inhibitor
5%
Vaccine Breakthrough
5%
SARS-CoV-2 Omicron
5%
Breakthrough Infection
5%
Omicron BA.1
5%
Cross-neutralization
5%
Human Detection
5%
Cross-resistance
5%
DNA Sequencing
5%
Line Probe Assay
5%
Drug Resistance mutations
5%
Omicron BA.2
5%
Omicron BA.5
5%
Replication Fitness
5%
In Silico Evaluation
5%
Nevirapine Resistance
5%
Biochemistry, Genetics and Molecular Biology
Human Immunodeficiency Virus 1
45%
Human Immunodeficiency Virus
27%
Co-Receptor
14%
Recombinant
12%
Virus Load
11%
Protease
11%
Prevalence
9%
CCR5
9%
Genotyping
8%
Structural Gene
8%
CXCR4
8%
Subtyping
8%
Protein Sequencing
5%
Genetics
5%
CD4 Lymphocyte Count
5%
Drug Resistance
5%
Wassermann Test
5%
Virus Neutralization
5%
SARS Coronavirus
5%
Blood Plasma
5%
Neutralizing Antibody
5%
Virus Infectivity
5%
Hepatitis C Virus
5%
Shotgun Sequencing
5%
